TREE NEWS reports: Novartis shares fell 10% in European trading after the company disclosed its third clinical trial setback within a week. The latest failure adds to investor concerns over the pharma giant’s pipeline. No further details were provided in the initial report.
Novartis shares drop 10% after third clinical trial setback in a week
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
12m ago
Apple’s foldable iPhone initial output reportedly just hundreds a day
35m ago
Amazon Mandates Banks for First Sterling Bond Sale
38m ago
Yen traders eye 100 per dollar as extreme but possible
41m ago
Hang Seng Index closes down 0.38%; TECH Index falls 1.28%
52m ago
Haiguang Xinzheng Surges 40% on Hong Kong Connect Inclusion
55m ago
BYD Sets 2027 Overseas Sales Target Above 2.5 Million Units